Model-based clinical pharmacology profiling of ipilimumab in patients with advanced melanoma - Wikidata - wikimedia - TriplyDB

Model-based clinical pharmacology profiling of ipilimumab in patients with advanced melanoma

Model-based clinical pharmacology profiling of ipilimumab in patients with advanced melanoma

http://www.wikidata.org/entity/Q34209549

about

Nivolumab dose selection: challenges, opportunities, and lessons learned for cancer immunotherapy Model-Based Population Pharmacokinetic Analysis of Nivolumab in Patients With Solid Tumors.Population Pharmacokinetic Meta-Analysis of Ramucirumab in Cancer Patients.Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy.Fixed Dosing of Monoclonal Antibodies in Oncology.Immunotherapy and Novel Combinations in Oncology: Current Landscape, Challenges, and Opportunities.Monoclonal antibodies for treating gastric cancer: promises and pitfalls.Impact of Shed/Soluble targets on the PK/PD of approved therapeutic monoclonal antibodies.From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials Wisely.Ipilimumab for the treatment of metastatic prostate cancer.Clinical Pharmacology Considerations for the Development of Immune Checkpoint Inhibitors.An open-label, multiple ascending dose study of the anti-CTLA-4 antibody ipilimumab in viremic HIV patients.Pharmacometric Applications and Challenges in the Development of Therapeutic Antibodies in Immuno-Oncology

P2860

Q37414886-62A56536-5E22-4AAB-AE92-81FA77E63BBD Q37609786-E2B09FED-A18B-41EE-B1FD-559A6CCAA4B6 Q38612237-5BF915C5-A752-484D-8E1C-403BA256A4E5 Q38615337-869B3F41-01CE-48E4-A9FD-D78BF344D66F Q38654371-3061A57C-34B1-4E1E-A4C2-6F3A26E7715D Q38753955-04F72881-F188-44B4-9632-BACF830B0FCD Q38772049-3760A819-435C-4E50-B71B-4D433BDA9562 Q38987211-50B40A19-2F54-4A86-A9F6-2CAF3DBE34EC Q45952214-09466286-F226-43C4-BE65-7D312EA3DAF6 Q47225399-F24503B6-5E9F-4D78-8E88-FB7662A4417B Q47943881-D2740BDD-255C-4A70-ADC8-F37728E83D7A Q55450663-BFFA946B-A64E-4A0D-8975-ADB78CB45F2B Q57495826-232E049C-BC05-40AC-8C70-2E229C093C82

P2860

Model-based clinical pharmacology profiling of ipilimumab in patients with advanced melanoma

http://www.wikidata.org/entity/Q34209549

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Model-based clinical pharmacol ...... atients with advanced melanoma

@ast

Model-based clinical pharmacol ...... atients with advanced melanoma

@en

Model-based clinical pharmacol ...... atients with advanced melanoma

@nl

type

label

Model-based clinical pharmacol ...... atients with advanced melanoma

@ast

Model-based clinical pharmacol ...... atients with advanced melanoma

@en

Model-based clinical pharmacol ...... atients with advanced melanoma

@nl

prefLabel

Model-based clinical pharmacol ...... atients with advanced melanoma

@ast

Model-based clinical pharmacol ...... atients with advanced melanoma

@en

Model-based clinical pharmacol ...... atients with advanced melanoma

@nl

P1433

Q34209549-BA762ED1-98A7-4965-87E0-0C44951B623B

P1476

Q34209549-39AEF425-7806-4F81-A2C8-D29E5A920DAF

P2093

Q34209549-22E3624D-8748-4AC2-81F2-25D50CAF4C3D

Q34209549-31B8B45E-049B-4FB6-9EF1-9D9D184EF448

Q34209549-722995BC-219D-4B76-B6D1-B0164378EC35

Q34209549-8263B119-6ABC-4CF2-A663-F24129170A2D

Q34209549-9CF54E15-F3E1-4809-B0F3-4D768421FB11

Q34209549-CE31CDF4-AF5D-4B79-A67A-CC3A4E52AECC

P2860

Q34209549-0C1ADF63-6282-4814-8886-D100CFF35C0A

Q34209549-1B03D189-0872-479F-86D4-B0336014000F

Q34209549-1F8EF7D3-F559-4A97-9C1F-052FB2585EBA

Q34209549-3EC81734-995C-4185-92B4-70FFF6B59B68

Q34209549-43299BB0-9759-4E5D-B798-1B1755079EB7

Q34209549-5518413D-401B-4566-9F38-6DE283612D8E

Q34209549-607734CB-3080-4802-BA6F-EDD7CFC16309

Q34209549-803D3324-76A6-4DF1-B69F-8C46BB35E73F

Q34209549-8C3587CF-F0D8-48C5-9A18-F985E095FEEC

Q34209549-8E3B4A7A-D4BB-4600-8C30-C4C0B581091B

P304

Q34209549-BE0AF242-79FF-4347-A37C-1CD14E72B464

P31

Q34209549-46485E0D-7304-4194-BD90-5402786E7C37

P356

Q34209549-1E294540-1683-4712-A634-A36F69ADBBF7

P407

Q34209549-6B0B5DB0-B5A7-462D-B18B-56D3499CA650

P433

Q34209549-E95AADEB-FBE7-4E8B-A057-D179BF2F86C7

P478

Q34209549-B5B85FA9-788F-4947-A4FE-CDD3D78DCE22

P577

Q34209549-FE28B0D1-D0FA-4DC2-9F04-2C5184FE84DD

P5875

Q34209549-94A691FE-AE8D-450A-BEE3-7619DE88D8EA

P698

Q34209549-70B5C567-61FA-4BF1-B47A-850EA9C47B50

P921

Q34209549-29A3F545-8C53-4E03-AE17-7DE74377ECCB

Q34209549-E0340758-009C-4D15-A77D-105A3D142C16

P932

Q34209549-B6078C7D-B4CD-4F38-97ED-94610AA20F14

P356

P1433

British Journal of Clinical Pharmacology

P1476

Model-based clinical pharmacol ...... atients with advanced melanoma

@en

P2093

Amit Roy

http://www.w3.org/2001/XMLSchema#string

David Berman

http://www.w3.org/2001/XMLSchema#string

David Dai

http://www.w3.org/2001/XMLSchema#string

Eric Masson

http://www.w3.org/2001/XMLSchema#string

Susan M Parker

http://www.w3.org/2001/XMLSchema#string

Yan Feng

http://www.w3.org/2001/XMLSchema#string

P2860

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

Phase I study of vorinostat in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group study.

Development of ipilimumab: contribution to a new paradigm for cancer immunotherapy.

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study.

Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study.

A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma.

Immunostimulatory monoclonal antibodies for cancer therapy.

The clinical pharmacology of therapeutic monoclonal antibodies in the treatment of malignancy; have the magic bullets arrived?

P304

106-117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BCP.12323

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259768600

http://www.w3.org/2001/XMLSchema#string

P698

24433434

http://www.w3.org/2001/XMLSchema#string

P921

P932

4168385

http://www.w3.org/2001/XMLSchema#string